Corinne S. De Vries

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Adverse outcomes among pregnant women with COVID-19 according to hospitalization status: A prospective individual participant data meta-analysis in Europe and North America.

Adverse outcomes among pregnant women with COVID-19 according to hospitalization status: A prospective individual participant data meta-analysis in Europe and North America.

Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Published: April 07, 2025

Review on organs-on-chips for medicines safety assessment: A European regulatory perspective.

Review on organs-on-chips for medicines safety assessment: A European regulatory perspective.

Journal: ALTEX

Published: February 06, 2025

Medications Used Among Nonhospitalized Pregnant Women With COVID-19: A Prospective Individual Patient Data Meta-Analysis in Europe and North America.

Medications Used Among Nonhospitalized Pregnant Women With COVID-19: A Prospective Individual Patient Data Meta-Analysis in Europe and North America.

Journal: Pharmacoepidemiology and drug safety

Published: January 29, 2025

EMA perspective on the value of model-informed drug development for labeling recommendations regarding medicine use during pregnancy and breastfeeding.

EMA perspective on the value of model-informed drug development for labeling recommendations regarding medicine use during pregnancy and breastfeeding.

Journal: CPT: pharmacometrics & systems pharmacology

Published: May 23, 2024

Identification of Pregnancy Adverse Drug Reactions in Pharmacovigilance Reporting Systems: A Novel Algorithm Developed in EudraVigilance.

Identification of Pregnancy Adverse Drug Reactions in Pharmacovigilance Reporting Systems: A Novel Algorithm Developed in EudraVigilance.

Journal: Drug safety

Published: May 16, 2024

Involvement of the European Medicines Agency in multi-stakeholder regulatory science research projects: experiences of staff members and project coordinators.

Involvement of the European Medicines Agency in multi-stakeholder regulatory science research projects: experiences of staff members and project coordinators.

Journal: Frontiers in medicine

Published: March 07, 2023

Assuring Access to Safe Medicines in Pregnancy and Breastfeeding.

Assuring Access to Safe Medicines in Pregnancy and Breastfeeding.

Journal: Clinical pharmacology and therapeutics

Published: January 07, 2021

Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap.

Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap.

Journal: Drug discovery today

Published: July 30, 2020

A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function.

A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function.

Journal: Inflammatory bowel diseases

Published: March 23, 2018

The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease.

The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease.

Journal: Journal of Crohn's & colitis

Published: September 19, 2016

Medicine safety in pregnancy and ambitions for the EU medicine regulatory framework.

Medicine safety in pregnancy and ambitions for the EU medicine regulatory framework.

Journal: Clinical pharmacology and therapeutics

Published: April 10, 2016

Healthcare databases in Europe for studying medicine use and safety during pregnancy.

Healthcare databases in Europe for studying medicine use and safety during pregnancy.

Journal: Pharmacoepidemiology and drug safety

Published: November 19, 2013

Showing 1-12 of 24

Last Updated: 09/26/2026